Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George M Solomon

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
International Journal of Caring Sciences|November 9, 2020
Gaming Console Home-Based Exercise for Adults with Cystic Fibrosis: Study ProtocolJohn D Lowman, George M Solomon, Steven M Rowe, et al.
Chest|March 4, 2015
Improved clinical and radiographic outcomes after treatment with ivacaftor in a young adult with cystic fibrosis with the P67L CFTR mutationShatha Yousef, George M Solomon, Alan Brody, et al.
ATS Scholar|April 24, 2023
Pilot Evaluation of a Management Toolkit for Airway Clearance Therapy in Bronchiectasis (IMPACT BE)George M Solomon, Alan F Barker, Elizabeth McSpiritt, et al.
BMC Pulmonary Medicine|April 27, 2019
Employment of an algorithm of care including chest physiotherapy results in reduced hospitalizations and stability of lung function in bronchiectasisJordan Powner, Andrew Nesmith, Denay P Kirkpatrick, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|March 30, 2026
Clinical Characteristics and Health Care Resource Utilization Among Individuals Undergoing Alpha-1 Antitrypsin Testing in a Quaternary Health SystemDrew D Robinson, Chia-Ying Chiu, Jane I Hampton, et al.
Frontiers in Immunology|February 9, 2026
Modulation of host inflammatory pathways by <i>Pseudomonas aeruginosa</i> extracellular vesicles in cystic fibrosis: impact of pulmonary exacerbation and elexacaftor-tezacaftor-ivacaftor treatmentMarianna Said, Aszia Burrell, Brennan Harmon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2016
Therapeutic benefit observed with the CFTR potentiator, ivacaftor, in a CF patient homozygous for the W1282X CFTR nonsense mutationVenkateshwar Mutyam, Emily Falk Libby, Ning Peng, et al.
Journal of Visualized Experiments : Jove|October 2, 2018
Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD)George M Solomon, Inez Bronsveld, Kathryn Hayes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 4, 2017
A multiple reader scoring system for Nasal Potential Difference parametersGeorge M Solomon, Bo Liu, Isabelle Sermet-Gaudelus, et al.
Research Square|April 25, 2024
Effects of High Frequency Chest Wall Oscillation (HFCWO) on Clinical Symptoms in COPDMeaghan M Bruner, Clarissa Bazan, Bo Liu, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
International Journal of Caring Sciences|November 9, 2020
Gaming Console Home-Based Exercise for Adults with Cystic Fibrosis: Study ProtocolJohn D Lowman, George M Solomon, Steven M Rowe, et al.
Chest|March 4, 2015
Improved clinical and radiographic outcomes after treatment with ivacaftor in a young adult with cystic fibrosis with the P67L CFTR mutationShatha Yousef, George M Solomon, Alan Brody, et al.
ATS Scholar|April 24, 2023
Pilot Evaluation of a Management Toolkit for Airway Clearance Therapy in Bronchiectasis (IMPACT BE)George M Solomon, Alan F Barker, Elizabeth McSpiritt, et al.
BMC Pulmonary Medicine|April 27, 2019
Employment of an algorithm of care including chest physiotherapy results in reduced hospitalizations and stability of lung function in bronchiectasisJordan Powner, Andrew Nesmith, Denay P Kirkpatrick, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|March 30, 2026
Clinical Characteristics and Health Care Resource Utilization Among Individuals Undergoing Alpha-1 Antitrypsin Testing in a Quaternary Health SystemDrew D Robinson, Chia-Ying Chiu, Jane I Hampton, et al.
Frontiers in Immunology|February 9, 2026
Modulation of host inflammatory pathways by <i>Pseudomonas aeruginosa</i> extracellular vesicles in cystic fibrosis: impact of pulmonary exacerbation and elexacaftor-tezacaftor-ivacaftor treatmentMarianna Said, Aszia Burrell, Brennan Harmon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2016
Therapeutic benefit observed with the CFTR potentiator, ivacaftor, in a CF patient homozygous for the W1282X CFTR nonsense mutationVenkateshwar Mutyam, Emily Falk Libby, Ning Peng, et al.
Journal of Visualized Experiments : Jove|October 2, 2018
Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD)George M Solomon, Inez Bronsveld, Kathryn Hayes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 4, 2017
A multiple reader scoring system for Nasal Potential Difference parametersGeorge M Solomon, Bo Liu, Isabelle Sermet-Gaudelus, et al.
Research Square|April 25, 2024
Effects of High Frequency Chest Wall Oscillation (HFCWO) on Clinical Symptoms in COPDMeaghan M Bruner, Clarissa Bazan, Bo Liu, et al.
Pageof 9